New drug approval: Adjuvant Pembrolizumab in clear-cell renal-cell carcinoma at high risk for recurrence after nephrectomy
BULLETIN DU CANCER（2022）
关键词
Clear-cell renal-cell carcinoma,Immunotherapy,Pembrolizumab,Adjuvant
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要